BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 7509852)

  • 1. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
    Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
    J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
    Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
    Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19.
    Moscinski LC; Trudeau WL; Fields KK; Elfenbein GJ
    Diagn Mol Pathol; 1996 Sep; 5(3):173-80. PubMed ID: 8866230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene.
    Luppi M; Morselli M; Bandieri E; Federico M; Marasca R; Barozzi P; Ferrari MG; Savarino M; Frassoldati A; Torelli G
    Ann Oncol; 1996 Aug; 7(6):619-24. PubMed ID: 8879377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.
    Slade MJ; Smith BM; Sinnett HD; Cross NC; Coombes RC
    J Clin Oncol; 1999 Mar; 17(3):870-9. PubMed ID: 10071278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA.
    Vannucchi AM; Bosi A; Glinz S; Pacini P; Linari S; Saccardi R; Alterini R; Rigacci L; Guidi S; Lombardini L; Longo G; Mariani MP; Rossi-Ferrini P
    Br J Haematol; 1998 Dec; 103(3):610-7. PubMed ID: 9858208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
    Fields KK; Elfenbein GJ; Trudeau WL; Perkins JB; Janssen WE; Moscinski LC
    J Clin Oncol; 1996 Jun; 14(6):1868-76. PubMed ID: 8656255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of nonmelanoma skin cancer micrometastases in lymph nodes by using reverse transcriptase-polymerase chain reaction for keratin 19 mRNA.
    Kamiya M; Ichiki Y; Kamiya H; Yamamoto A; Kitajima Y
    Br J Dermatol; 2003 Nov; 149(5):998-1005. PubMed ID: 14632805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
    Wulf GG; Jürgens B; Liersch T; Gatzemeier W; Rauschecker H; Buske C; Hüfner M; Hiddemann W; Wörmann B
    J Cancer Res Clin Oncol; 1997; 123(9):514-21. PubMed ID: 9341902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
    Zippelius A; Kufer P; Honold G; Köllermann MW; Oberneder R; Schlimok G; Riethmüller G; Pantel K
    J Clin Oncol; 1997 Jul; 15(7):2701-8. PubMed ID: 9215843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction.
    Gunn J; McCall JL; Yun K; Wright PA
    Lab Invest; 1996 Oct; 75(4):611-6. PubMed ID: 8874391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.
    Gerhard M; Juhl H; Kalthoff H; Schreiber HW; Wagener C; Neumaier M
    J Clin Oncol; 1994 Apr; 12(4):725-9. PubMed ID: 7512130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1996 Sep; 78(6):1235-40. PubMed ID: 8826945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.
    Jung YS; Lee KJ; Kim HJ; Yim HE; Park JS; Soh EY; Kim MW; Park HB
    Jpn J Clin Oncol; 2003 Apr; 33(4):167-72. PubMed ID: 12810830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
    Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
    J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
    Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
    Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of bone marrow-disseminated breast cancer cells using an RT-PCR assay of MUC5B mRNA.
    Berois N; Varangot M; Sóñora C; Zarantonelli L; Pressa C; Laviña R; Rodríguez JL; Delgado F; Porchet N; Aubert JP; Osinaga E
    Int J Cancer; 2003 Feb; 103(4):550-5. PubMed ID: 12478674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of metastatic breast cancer by beta-hCG polymerase chain reaction.
    Hoon DS; Sarantou T; Doi F; Chi DD; Kuo C; Conrad AJ; Schmid P; Turner R; Guiliano A
    Int J Cancer; 1996 Oct; 69(5):369-74. PubMed ID: 8900369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.